Go Pro

Frank Rimerman Advisors LLC Takes $1.04 Million Position in Marsh & McLennan Companies, Inc. $MRSH

Marsh & McLennan Companies logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Frank Rimerman Advisors disclosed a new position in Marsh & McLennan Companies, buying 5,994 shares worth about $1.04 million in the first quarter.
  • Analyst sentiment remains mixed but generally constructive: UBS and Cantor Fitzgerald both raised price targets, with the stock’s consensus rating sitting at Hold and an average target of $200.44.
  • Marsh & McLennan boosted its quarterly dividend 10% to $0.99 per share, while its latest earnings topped estimates and revenue rose 7.6% year over year.
  • Interested in Marsh & McLennan Companies? Here are five stocks we like better.

Frank Rimerman Advisors LLC purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,994 shares of the financial services provider's stock, valued at approximately $1,040,000.

A number of other institutional investors have also added to or reduced their stakes in MRSH. Headlands Technologies LLC bought a new stake in shares of Marsh & McLennan Companies during the 2nd quarter valued at $29,000. Solstein Capital LLC purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $25,000. SHP Wealth Management bought a new position in shares of Marsh & McLennan Companies in the 4th quarter worth about $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in Marsh & McLennan Companies during the fourth quarter worth about $27,000. Finally, Golden State Wealth Management LLC purchased a new stake in Marsh & McLennan Companies in the fourth quarter worth about $27,000. Institutional investors own 87.99% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on MRSH shares. JPMorgan Chase & Co. decreased their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research note on Thursday, April 9th. Cantor Fitzgerald upped their price target on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an "overweight" rating in a research note on Thursday. Wells Fargo & Company lowered their price objective on Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating for the company in a research note on Thursday, April 9th. Piper Sandler dropped their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating on the stock in a report on Tuesday, May 26th. Finally, Keefe, Bruyette & Woods increased their target price on Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a "market perform" rating in a research note on Friday, April 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies has a consensus rating of "Hold" and an average price target of $200.44.

Check Out Our Latest Research Report on Marsh & McLennan Companies

Marsh & McLennan Companies Stock Performance

MRSH opened at $178.81 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The stock has a market cap of $86.38 billion, a price-to-earnings ratio of 22.35, a P/E/G ratio of 2.61 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a 52-week low of $156.60 and a 52-week high of $216.32.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies's revenue for the quarter was up 7.6% compared to the same quarter last year. On average, sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 10.37 earnings per share for the current fiscal year.

Marsh & McLennan Companies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd will be paid a dividend of $0.99 per share. The ex-dividend date is Thursday, July 23rd. This represents a $3.96 dividend on an annualized basis and a yield of 2.2%. This is a boost from Marsh & McLennan Companies's previous quarterly dividend of $0.90. Marsh & McLennan Companies's dividend payout ratio (DPR) is presently 45.00%.

Key Headlines Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

Insider Buying and Selling at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the firm's stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Featured Articles

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Marsh & McLennan Companies Right Now?

Before you consider Marsh & McLennan Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.

While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines